Marginalization Quintilea Marginalization Quintilea Marginalization Quintilea
Q1 Q3 Q5 p-value
N (%) 4107 4731 3111
Age
18-39 40-49 50-59 60-69 70-79 80+ 48 (1.2) 255 (6.2) 1176 (28.7) 1507 (36.7) 831 (20.2) 290 (7.1) 105 (2.2) 371 (7.8) 1261 (26.7) 1624 (34.3) 919 (19.4) 451 (9.5) 82 (2.6) 257 (8.2) 835 (26.8) 1065 (34.2) 556 (18.9) 316 (10.2)
<0.001
Charlson Score
0 1-2 3+ No Admissionb 1102 (26.8) 886 (21.6) 176 (4.3) 1943 (47.3) 1093 (23.1) 1112 (23.5) 279 (5.9) 2247 (47.5) 629 (20.2) 740 (23.8) 204 (6.6) 1538 (49.4)
<0.001
Severe Obesity BMI>40 718 (17.5) 836 (17.7) 558 (17.9) 0.80
Income Quintile
1 2 3 4 5 30 (0.7) 210 (5.1) 587 (14.3) 1172 (28.5) 2107 (51.3) 539 (11.4) 1287 (27.2) 1452 (30.7) 959 (20.3) 493 (10.4) 1986 (64.0) 771 (24.9) 207 (6.7) 86 (2.8) 53 (1.7)
<0.001
Rural Residence 877 (21.4) 507 (10.7) NR <0.001
Histology
Endometrioid Serous Mixed Carcinosarcoma Clear Cell Undifferentiated Other/Missing 3095 (75.4) 153 (3.7) 60 (1.5) 248 (6.0) 164 (4.0) 54 (1.3) 333 (8.1) 3409 (72.1) 194 (4.1) 67 (1.4) 355 (7.5) 180 (3.8) 60 (1.3) 466 (9.9) 2199 (70.7) 305 (9.8) 241 (7.8) 147 (4.7) 43 (1.4) 58 (1.9) 118 (3.8)
<0.001
Stage
1 2 3 4 Unknown 2281 (55.5) 264 (6.4) 298 (7.3) 180 (4.4) 1084 (26.4) 2419 (51.1) 325 (6.9) 364 (7.7) 174 (3.7) 1449 (30.6) 1506 (48.4) 195 (6.3) 289 (9.3) 148 (4.8) 973 (31.3)
<0.001
Prior Cancerc 224 (5.5) 219 (4.6) 151 (4.9) 0.42
No Surgery Performed 299 (7.3) 435 (9.2) 332 (10.7) <0.001
Surgery >180d after diagnosis 81 (2.0) 113 (2.4) 84 (2.7)
MISd 1374 (36.1) 1629 (37.9) 1097 (39.5) 0.006
Surgeon Specialty
Gynecologic Oncologist General Gynecologist Other/Unknown 1574 (41.3) 1971 (51.8) 273 (6.9) 1711 (39.8) 2258 (52.6) 327 (7.7) 1196 (43.0) 1370 (49.3) 213 (7.6)
<0.001
Hospital Type for Surgery
Community Teaching Other/Unknown 1912 (50.2) 1556 (40.9) 340 (9.0) 2322 (54.1) 1562 (36.4) 412 (9.6) 1261 (45.4) 1204 (43.3) 314 (11.3)
<0.001